Karel Kostev։ When First Anticoagulant Prescriptions Are Not Dispensed
Karel Kostev, Senior Scientific Principal at IQVIA, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiovascular Development and Disease, adding:
”New publication in the Journal of Cardiovascular Development and Disease.
How often is a first oral anticoagulant prescription for atrial fibrillation (AF) never dispensed?
We analysed 57,290 first prescriptions in 53,815 AF patients in Germany (2016–2025), using the IQVIA Disease Analyzer and LRx databases.
Key findings:
- Primary non-adherence (PNA), i.e. no dispensing within 30 days, occurred in 10.6 percent of prescriptions
- PNA was highest for vitamin K antagonists (14.4 percent) and lowest for apixaban and edoxaban (9.6 percent each)
- Direct factor Xa inhibitors were associated with 33 percent lower odds of PNA than vitamin K antagonists
- Prior myocardial infarction and dementia were associated with lower PNA; ischemic heart disease and hypertension with higher PNA
- Almost half of non-dispensed prescriptions were dispensed later
- Non-dispensing of the first prescription was strongly associated with later non-dispensing
General practitioners and pharmacists can use these findings to confirm early whether anticoagulation has actually started, especially for vitamin K antagonists.”
Title: Primary Non-Adherence and Associated Factors in Patients with Atrial Fibrillation in Germany: A Retrospective Cohort Study
Authors: Karel Kostev, Beate Leppert, Maximilian Peters, Henning Sievert, Marcel Konrad, Mark Luedde

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series